Treatment fluids containing biodegradable chelating agents and methods for use thereof

1. A method comprising:

providing a treatment fluid that comprises:

an aqueous base fluid;

a chelating agent composition comprising methylglycine diacetic acid, any salt thereof, any derivative thereof, or any combination thereof;

a viscoelastic surfactant in an amount from about 0.5% to about 10% by volume of the treatment fluid; and

a cosurfactant in an amount from about 0.05% to about 5% by volume of the treatment fluid;

wherein the treatment fluid has a pH of about 1.5 to about 1.8; and

introducing the treatment fluid into at least a portion of a subterranean formation as a preventative treatment before a subsequent fracturing treatment;

wherein the preventative treatment prevents the formation of precipitates in the subterranean formation upon dissolution of metal cations by an acid.

2. The method of claim 1 , wherein the treatment fluid further comprises hydrofluoric acid or a hydrofluoric acid generating compound that is selected from the group consisting of fluoroboric acid, fluorosulfuric acid, hexafluorophosphoric acid, hexafluoroantimonic acid, difluorophosphoric acid, hexafluorosilicic acid, potassium hydrogen difluoride, sodium hydrogen difluoride, boron trifluoride acetic acid complex, boron trifluoride phosphoric acid complex, boron trifluoride dihydrate, polyvinylammonium fluoride, polyvinylpyridinium fluoride, pyridinium fluoride, imidazolium fluoride, ammonium fluoride, ammonium bifluoride, tetrafluoroborate salts, hexafluoroantimonate salts, hexafluorophosphate salts, bifluoride salts, and any combination thereof.

3. The method of claim 1 , further comprising:

performing a stimulation operation in the portion of the subterranean formation.

4. The method of claim 1 , further comprising:

treating a pipe comprising a well bore penetrating the subterranean formation.

5. The method of claim 1 , wherein introducing the treatment fluid takes place at a pressure that is less than a fracturing pressure of the subterranean formation.

6. A method comprising:

providing a treatment fluid that comprises:

an aqueous base fluid;

a chelating agent composition comprising a first chelating agent comprising methylglycine diacetic acid, any salt thereof, any derivative thereof, or any combination thereof, and a second chelating agent selected from the group consisting of β-alanine diacetic acid, ethylenediaminedisuccinic acid, S,S-ethylenediaminedisuccinic acid, iminodisuccinic acid, hydroxyiminodisuccinic acid, polyamino disuccinic acids, N-bis[2-(1,2-dicarboxyethoxyl)ethyl]glycine, N-bis[2-(1,2-dicarboxyethoxyl)ethyl]aspartic acid, N-bis[2-(1,2-dicarboxyethoxyl)ethyl]methylglycine, N-tris[(1,2-dicarboxyethoxy)ethyl]amine, N-methyliminodiacetic acid, iminodiacetic acid, N-(2-acetamido)iminodiacetic acid, hydroxymethyl-iminodiacetic acid, 2-(2-carboxyethylamino) succinic acid, 2-(2-carboxymethylamino) succinic acid, diethylenetriamine-N,N″-disuccinic acid, triethylenetetramine-N,N′″-disuccinic acid, 1,6-hexamethylenediamine-N,N′-disuccinic acid, tetraethylenepentamine-N,N″″-disuccinic acid, 2-hydroxypropylene-1,3-diamine-N,N′-disuccinic acid, 1,2-propylenediamine-N,N′-disuccinic acid, 1,3-propylenediamine-N,N′-disuccinic acid, cis-cyclohexanediamine-N,N′-disuccinic acid, trans-cyclohexanediamine-N,N′-disuccinic acid, ethylenebis(oxyethylenenitrilo)-N,N′-disuccinic acid, glucoheptanoic acid, cysteic acid-N,N-diacetic acid, cysteic acid-N-monoacetic acid, alanine-N-monoacetic acid, N-(3-hydroxysuccinyl) aspartic acid, N-[2-(3-hydroxysuccinyl)]-L-serine, aspartic acid-N,N-diacetic acid, aspartic acid-N-monoacetic acid, glutamic acid diacetic acid, any salt thereof, any derivative thereof, and any combination thereof;

a viscoelastic surfactant in an amount from about 0.5% to about 10% by volume of the treatment fluid; and

a cosurfactant in an amount from about 0.05% to about 5% by volume of the treatment fluid;

wherein the treatment fluid has a pH of about 1.5 to about 1.8; and

introducing the treatment fluid into at least a portion of a subterranean formation as a preventative treatment before a subsequent fracturing treatment;

wherein the preventative treatment prevents formation of precipitates in the subterranean formation upon dissolution of metal cations by an acid.

7. The method of claim 6 , wherein the treatment fluid further comprises hydrofluoric acid or a hydrofluoric acid generating compound.

8. The method of claim 7 , wherein the hydrofluoric acid generating compound is selected from the group consisting of fluoroboric acid, fluorosulfuric acid, hexafluorophosphoric acid, hexafluoroantimonic acid, difluorophosphoric acid, hexafluorosilicic acid, potassium hydrogen difluoride, sodium hydrogen difluoride, boron trifluoride acetic acid complex, boron trifluoride phosphoric acid complex, boron trifluoride dihydrate, polyvinylammonium fluoride, polyvinylpyridinium fluoride, pyridinium fluoride, imidazolium fluoride, ammonium fluoride, ammonium bifluoride, tetrafluoroborate salts, hexafluoroantimonate salts, hexafluorophosphate salts, bifluoride salts, and any combination thereof.

9. The method of claim 7 , wherein the chelating agent composition is substantially free of alkali metals and comprises an ammonium or tetraalkylammonium salt of at least one of the chelating agents.